Because GLP-1 drugs slow stomach emptying, some doctors recommend temporarily stopping medications like Ozempic, Wegovy or Zepbound before surgery or procedures involving anesthesia
Obesity and overweight, which are common in patients with DM2, are a factors that favor the development/progression of CKD through both direct and indirect effects.69 Although the precise mechanisms the association between obesity and CKD are not totally defined it has been proposed that hypertension, glomerular hyperfiltration, hyperglycemia, lipid toxicity, inflammation or the role of adipose tissue and its adipokines are involved.70 Weight reduction by bariatric surgery, pharmacological treatment or dietary measures are associated with a nephroprotective effect,7173 so that weight reduction is a fundamental objective in the nephroprotection of patients with DKD
Los agonistas del GLP-1 son medicamentos desarrollados originalmente para el tratamiento de la diabetes que imitan nuestra propia hormona GLP-1, afirma la Dra
Super easy to build
The Trial The ATTAIN-MAINTAIN trial enrolled patients who had achieved substantial weight loss that had plateaued while taking weekly injectable GLP-1s in the SURMOUNT-5 trial
